Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.140
-0.090 (-7.32%)
At close: Apr 1, 2025, 4:00 PM
1.274
+0.134 (11.74%)
After-hours: Apr 1, 2025, 4:38 PM EDT

Marker Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
6.593.313.511.240.47
Upgrade
Revenue Growth (YoY)
99.06%-5.76%182.96%166.01%118.95%
Upgrade
Cost of Revenue
-10.4211.9727.7918.88
Upgrade
Gross Profit
6.59-7.11-8.45-26.55-18.41
Upgrade
Selling, General & Admin
4.247.4811.3412.9210.47
Upgrade
Research & Development
13.47----
Upgrade
Operating Expenses
17.717.4811.3412.9210.47
Upgrade
Operating Income
-11.12-14.58-19.79-39.48-28.89
Upgrade
Interest & Investment Income
0.440.540.250.010.15
Upgrade
Other Non Operating Income (Expenses)
----0.03
Upgrade
EBT Excluding Unusual Items
-10.68-14.04-19.54-39.47-28.71
Upgrade
Other Unusual Items
---0.23-2.41-
Upgrade
Pretax Income
-10.68-14.04-19.78-41.88-28.71
Upgrade
Income Tax Expense
0.050---
Upgrade
Earnings From Continuing Operations
-10.73-14.05-19.78-41.88-28.71
Upgrade
Earnings From Discontinued Operations
-5.81-10.15--
Upgrade
Net Income
-10.73-8.24-29.93-41.88-28.71
Upgrade
Net Income to Common
-10.73-8.24-29.93-41.88-28.71
Upgrade
Shares Outstanding (Basic)
99885
Upgrade
Shares Outstanding (Diluted)
99885
Upgrade
Shares Change (YoY)
1.94%5.49%9.16%62.64%3.19%
Upgrade
EPS (Basic)
-1.19-0.94-3.58-5.47-6.10
Upgrade
EPS (Diluted)
-1.19-0.94-3.59-5.47-6.10
Upgrade
Free Cash Flow
-10.91-16.44-26.97-30.41-29.29
Upgrade
Free Cash Flow Per Share
-1.22-1.87-3.23-3.98-6.23
Upgrade
Gross Margin
100.00%-214.60%-240.64%--
Upgrade
Operating Margin
-168.69%-440.37%-563.28%-3179.32%-6188.25%
Upgrade
Profit Margin
-162.82%-248.76%-851.87%-3372.68%-6149.74%
Upgrade
Free Cash Flow Margin
-165.53%-496.51%-767.66%-2449.11%-6274.32%
Upgrade
EBITDA
--11.79-17-37.33-28.4
Upgrade
D&A For EBITDA
-2.792.792.150.49
Upgrade
EBIT
-11.12-14.58-19.79-39.48-28.89
Upgrade
EBIT Margin
-168.69%----
Upgrade
Revenue as Reported
6.593.313.511.240.47
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q